These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6616409)

  • 1. Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapy.
    Carlson JA; Edwards C; Wharton JT; Gallager HS; Delclos L; Rutledge F
    Cancer; 1983 Oct; 52(8):1473-7. PubMed ID: 6616409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide.
    Gershenson DM; Copeland LJ; Kavanagh JJ; Cangir A; Del Junco G; Saul PB; Stringer CA; Freedman RS; Edwards CL; Wharton JT
    Cancer; 1985 Dec; 56(12):2756-61. PubMed ID: 2996746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in chemotherapy for gynecologic cancer.
    Smith JP; Rutledge F
    Cancer; 1975 Aug; 36(2):669-74. PubMed ID: 1157027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study.
    van Nagell JR; Hanson MB; Donaldson ES; Gallion HH
    Cancer; 1986 Apr; 57(8):1451-4. PubMed ID: 3948125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
    Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
    Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide.
    Hannigan EV; Freedman RS; Elder KW; Rutledge FN
    Gynecol Oncol; 1983 Apr; 15(2):224-9. PubMed ID: 6687580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endodermal sinus tumor of ovary--analysis of 35 cases].
    Hou YJ
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):310-2. PubMed ID: 2625116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report).
    Slayton RE; Park RC; Silverberg SG; Shingleton H; Creasman WT; Blessing JA
    Cancer; 1985 Jul; 56(2):243-8. PubMed ID: 2988740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary.
    Wheelock J; Hancock K; Smith K
    Cancer Treat Rep; 1987 Dec; 71(12):1275-6. PubMed ID: 3690537
    [No Abstract]   [Full Text] [Related]  

  • 10. VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site.
    Anderson H; Thatcher N; Rankin E; Wagstaff J; Scarffe JH; Crowther D
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):49-52. PubMed ID: 6687868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary treatment with vincristine, dactinomycin, and cyclophosphamide in nondysgerminomatous germ cell tumor of the ovary.
    Wong LC; Ngan HY; Ma HK
    Gynecol Oncol; 1989 Aug; 34(2):155-8. PubMed ID: 2753421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with vincristin, actinomycin D, cyclophosphamide and adriamycin in soft-part sarcoma].
    Mori O; Takagi K; Kitagawa T; Harada M; Ogawa I
    Gan No Rinsho; 1986 Aug; 32(9):998-1004. PubMed ID: 3747164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.
    Williams SD; Blessing JA; Hatch KD; Homesley HD
    J Clin Oncol; 1991 Nov; 9(11):1950-5. PubMed ID: 1719142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy using vincristine, adriamycin, cyclophosphamide (VAC) alternating with ifosfamide and etoposide (IE) for advanced soft tissue sarcomas: a phase II study.
    Palumbo R; Palmeri S; Gatti C; Villani G; Cesca A; Toma S
    Oncol Rep; 1998; 5(1):69-72. PubMed ID: 9458296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy in early uterine sarcoma.
    Hannigan EV; Freedman RS; Rutledge FN
    Gynecol Oncol; 1983 Feb; 15(1):56-64. PubMed ID: 6401640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide].
    Huang H; Lian L; Huang R
    Zhonghua Fu Chan Ke Za Zhi; 1995 May; 30(5):265-9. PubMed ID: 7544256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy in the management of ovarian germ cell malignancies.
    Schwartz PE
    Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy of soft tissue sarcoma].
    Shinohara N; Yokoyama K
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):198-204. PubMed ID: 2301950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal pregnancy and delivery two years after adjuvant chemotherapy for grade III immature ovarian teratoma.
    Schneider J; Erasun F; Hervas JL; Acinas O; Gonzalez-Rodilla I
    Gynecol Oncol; 1988 Feb; 29(2):245-9. PubMed ID: 3338675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endodermal sinus tumor of the ovary: the M. D. Anderson experience.
    Gershenson DM; Del Junco G; Herson J; Rutledge FN
    Obstet Gynecol; 1983 Feb; 61(2):194-202. PubMed ID: 6185892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.